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Abstracts / International Journal of Surgery 12 (2014) S13eS117 S87Results: Alterations to timetablingmaximised cadaver use, and trainer and
trainee time. Twenty-two CSTs attended the second workshop. 50 opera-
tions with workplace based assessments were completed. Costs were £166
per operation (initial workshop, £203). All participants found FFC tissue
‘similar or very similar’ to live tissue and the course ‘useful or very useful’
to improve skills and conﬁdence. A modiﬁed DREEM score of 142/184 is an
‘excellent educational experience’.
Conclusions: Whole FFC can provide simulation of operative procedures
in a safe environment. Maximising FFCs means costs compare favourably
to lower ﬁdelity models. The model has potential for wider adoption.
1322: HEALTHCARE STAFF NUMBERS INVOLVED IN PATIENT-CARE IN AN
ACUTE SURGICAL PATIENT
Abhishek Sharma *,1,2, Duff Bruce 1,2, Manoj Kumar 1,2. 1Aberdeen Royal
Inﬁrmary, Aberdeen, UK; 2North Cumbria University Hospital NHS Trust,
Whitehaven, UK.
Introduction: Consultant treatment outcomes have been made available
to the public domain. It states how surgeons perform at NHS hospitals. We
sought to identify the number of healthcare personnel who are involved in
the care of a single patient in an NHS hospital, which may impact on
outcomes.
Methods: A retrospective case note review was performed on surgical
admissions in two general surgical wards in a teaching-hospital. Medical
and nursing rotas were analysed. All staff involved in the care of patients
were included.
Results: 55 admissions (average length-of-stay 2.1 days) under a single
surgical teamwere analysed. An average of 10.2 surgical staff (1 consultant,
10 juniors) and 5 nursing staff involved. Other specialist medical input was
provided in 5 patients.
Conclusions: The complexities involved in the management of individual
patients within the health service are signiﬁcant. The reliance on a multi-
disciplinary approach is invaluable. Encouraging a no-blame culturewithin
the NHS is pivotal in improving patient safety. The increased transparency
adapted by the health service is a positive step. However, publication of
outcomes from teams rather than individuals may help augment the two
former points and serve to improve quality improvement in the NHS.
1326: ASSOCIATION OF SURGEON'S IN TRAINING (ASIT) NATIONAL SUR-
GICAL MENTORING SCHEME PILOT: PRELIMINARY RESULTS
Piriyah Sinclair *, Frank McDermott, Peter Radford, Joseph Shalhoub,
Edward Fitzgerald. Association of Surgeons in Training (ASiT), UK.
Introduction: There is growing evidence that mentoring is beneﬁcial to
career satisfaction, progression and life/work balance. ASiT have devel-
oped a national mentoring scheme for surgical trainees, including coach-
ing training for mentors. This study undertakes preliminary evaluation of
the pilot currently running and identiﬁes challenges to its implementation.
Methods: All mentors and mentees volunteered to participate. Mentors
completed a formal training process with an accredited coach. All partic-
ipants signed a mentoring agreement, agreeing to a code of conduct. De-
mographics were obtained for all participants and meeting outcomes
recorded for later analysis.
Results: 18 trainees volunteered to become mentors. 7 dropped out (39%).
Mentors range from FY1 to Registrar, come from 6 surgical specialties and a
variety of training regions. 31 trainees applied to be mentees; 8 (26%)
dropped out. Mentees were from all training grades, 7 surgical specialties
and a variety of training regions. Matching was complicated by a disparity
in region and specialty, but video calls (e.g. Skype®) represented one
solution.
Conclusions: This pilot is a novel trainee-led scheme. Pilot evaluation has
highlighted important challenges including high drop-out rates. Dates for
mentoring training must be established in advance of advertising. Further
investigation is required to elucidate reasons for mentees leaving the
scheme.
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0356: VALGANCICLOVIR-INDUCED LECUOPENIA IN RENAL TRANSPLANT
RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL
Mohammed Abdul Waduud *, Margaret McMillan. NHS GGC, Glasgow, UK.
Introduction: Cytomegalovirus (CMV) is a viral infection commonly
affecting renal transplant recipients. Current guidelines recommend theprophylactic treatment of patients at risk from CMV with oral Valganci-
clovir (VGC), however, myelotoxic side effects have been reported. The
severity of leucopenia is reported to be increased when used in conjunc-
tion with Mycophenolate Mofetil (MMF), although some studies have
shown conﬂicting evidence.
Methods: Retrospective analysis of patient clinical data, post-renal-trans-
plant, was performed. Patients included were treated with; MMF and VGC
[MMF(+)VGC(+)],MMFbut notVGC [MMF(+)VGC(-)], noMMFbutwithVGC
[MMF(-)VGC(+)] and, neither MMF or VGC [MMF(-)VGC(-)]. Blood results
and other relevant data were collected from clinical databases.
Results: In total, data from 61 patients were analysed. 13 patients were
MMF(+)VGC(+), 48 patients were MMF(+)VGC(-), 5 patients were MMF(-)
VGC(+) and 12 patients were MMF(-)VGC(-). Of these, 6 MMF(+)VGC(+)
patients and 3 MMF(+)VGC(-) patients were leucopenic within the ﬁrst 3
months post-renal-transplant (p¼0.001). This difference was not apparent
in patients that were not treated with a MMF regime.
Conclusions: Patients treated with MMF and VGC are at a signiﬁcantly
higher risk of leucopenia when compared to patients not treated with
MMF and VGC in the ﬁrst 3 months post-renal-transplant.
0391: SIGNIFICANCE OF ILIAC ARTERIAL DISEASE IN A RENAL TRANS-
PLANT POPULATION
Rashmi D'Souza *, Martha Martin, Riccardo Tamburrini, Zubir Ahmed,
Martin Drage. Guy's Hospital, London, UK.
Introduction: The aetiology of iliac arterial disease in renal failure patients
is poorly understood despite major implications for transplantation
feasibility and lower limb viability. We investigated the incidence, clinical
impact and potential risk factors associated with iliac arterial disease.
Methods: 355 renal transplant recipients, who had pre-operative ultra-
sound iliac angiology (UA) - between January 2011 and December 2012,
were retrospectively analysed. Data were collected on: dialysis de-
pendency, BMI, statin use, blood pressure, hyperlipidaemia, smoking sta-
tus, calcium-phosphate product, diabetes, peripheral vascular disease
(PVD) and post-transplant surgical complications. Data were analysed
using SPSS univariate tests of association.
Results: The mean age was 47 years (SD14) and 65% of the cohort was
female. 40 patients (11%) had signiﬁcant iliac arterial disease on UA.
Postoperative arterial complication rates were equivalent between those
with normal and abnormal iliac vessels: 4% v 2% (p>0.05). Only advancing
age (>51 years) was signiﬁcantly associated with iliac arterial disease
(p¼0.007). Other aforementioned potential risk factors were not found to
be associated.
Conclusions: Iliac arterial disease is usually clinically silent and does not
affect the immediate success of transplantation. Except for advancing age,
traditional cardiovascular risk factors are not associated with iliac arterial
disease in this population.
0392: THE ECONOMIC COST VS. CLINICAL BENEFIT OF US ANGIOLOGY IN
RENAL TRANSPLANT RECIPIENTS
Martha Martin *, Rashmi D'Souza, Riccardo Tamburrini, Zubir Ahmed,
Martin Drage. Guy's Hospital, London, UK.
Introduction: Guidelines suggest that in at-risk kidney transplant re-
cipients, pre-operative ultrasound angiology (UA) should be used to
determine iliac vessel abnormalities. This is to enhance operative decision-
making over and above simple clinical examination. However UA is costly
and its clinical beneﬁt and economic value are not known within this
patient group.
Methods: We retrospectively collected data for 355 renal transplant re-
cipients between January 2011 and December 2012. The data we analysed
included UA results, abnormality of the femoral pulse on clinical exami-
nation and any documented changes in the operative management plan
such as change in laterality of kidney implantation.
Results: Of the 46/355 patients had abnormal results. 7/46 abnormal re-
sults led to a change in laterality of kidney implantation. 4 of these 7 pa-
tients had abnormalities on clinical examination. Thus for every 1 clinically
signiﬁcant iliac lesion identiﬁed the number needed to scan was 64. At a
unit cost of £120 the cost of identiﬁcation of one surgically important
lesion is £7680.
Conclusions: UA is costly and rarely changes the operative management
plan. More economically viable methods of assessing the technical feasi-
bility of kidney transplantation should be sought.
